This space will be used to advertise current oppportunities for snakebite researchers.
ANYSNAKES Trial
Prof David Lalloo, Chief Investigator of the ANYSNAKES trial is inviting colleagues working in African countries with a high burden of snakebite for a potential collaboration. This trial, funded by the Wellcome Trust and conducted by the Liverpool School of Tropical Medicine in partnership with the MRC Clinical Trials Unit, aims to assess the efficacy and safety of various antivenoms in reversing the acute effects of systemic envenoming. We are particularly keen to ensure broad geographic representation from countries with a high burden of snakebite across sub-Saharan Africa. Therefore, we are looking to connect with clinicians working in hospitals that treat a significant number of snakebite patients (more than 50 annually).
If you are interested in exploring this opportunity further please contact the trial’s Clinical Lead - Dr Frank Tianyi (frank.tianyi@lstmed.ac.uk).
Job Posting: Clinical Research Associate (French Speaking) at the Liverpool School of Tropical Medicine
Liverpool School of Tropical Medicine (LSTM) is a globally recognised centre of excellence for research and teaching in tropical diseases. Established 125 years ago, we are the oldest school of tropical medicine in the world and our mission is to reduce the burden of sickness and mortality in disease endemic countries. Our work makes a real difference to the people who need our help most, and it has been recognised by some highly prestigious awards, including business of the year by Liverpool Chamber of Commerce, and recently being ranked in the top 5.3% of universities in the world.
We are looking to hire a French speaking Clinical Research Associate to assist with the day to day running of the Wellcome Trust funded ANYSNAKES Clinical Trial in Africa. The successful candidate will report to Professor David Lalloo, Vice-Chancellor of Liverpool School of Tropical Medicine and PI for ANYSNAKES, and will support the team in successful delivery of the trial. In addition to this the successful candidate will provide clinical and epidemiological input into clinical snakebite-research projects being conducted by CSRI (The Centre for Snakebite Research & Innovation). This is a fantastic opportunity to gain experience in clinical research and in the running of a major international clinical trial. There will also be potential opportunities to undertake formal research training.
This post requires regular 2–3-week visits to hospitals and communities in rural African settings to establish and oversee activities related to clinical trial, delivering epidemiological advice and ensuring best practice for collection and storage of samples in line with international trial standards.
For more information, please visit the job posting.
Call for Submission in Special Issue in Tropical Medicine & Infectious Disease Journal
Snake Bite: Prevention, Diagnosis and Treatment
Message from the Guest Editors: Snakebite envenoming, causing 100,000 deaths and 400,000 injuries annually, is a critical neglected tropical disease. Its multifaceted nature demands tailored interventions, yet controlled studies confirming their efficacy are lacking. Diagnosis relies on clinical assessment, with lab tests aiding in monitoring and species identification. Antivenoms are crucial for treatment, tailored to local snake populations. Supportive medical care is vital, alongside management of physical and mental aftermath. Despite a rich pipeline of novel approaches, further research is needed for translation. The Special Issue invites submissions on prevention, diagnosis, and treatment interventions, including social science and operational research, epidemiological surveys, program descriptions, and clinical studies on conventional and investigational products. Reviews are also encouraged. Find more information on the journal's wepage here.
Deadline for manuscript submissions: 1 Feb 2025
12th International Toxinology Meeting: Venoms & Toxins 2025
You are warmly invited to attend the 2025 international toxinology conference “Venoms and Toxins 2025” which will be held on 26-28 August 2025 as a ‘virtual/in-person’ hybrid event. Building on the successes of past meetings, which demonstrated commitment to a diverse and inclusive programme, the 2025 conference will maintain this scientific excellence and originality, offering the toxinology community another exciting scientific agenda. Please visit the conference website for more information on how to register.